Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John D Baxter

Showing results (11-20 of 81) with videos related to

Pageof 9
Sort By:
Open Forum Infectious Diseases|August 13, 2025
HIV-1 Drug Resistance Trends in the Era of Modern Antiretrovirals: 2018-2024Ron M Kagan, John D Baxter, Taekkyun Kim, et al.
Molecular and Cellular Endocrinology|May 12, 2004
Towards selectively modulating mineralocorticoid receptor function: lessons from other systemsJohn D Baxter, John W Funder, James W Apriletti, et al.
Antiviral Therapy|August 27, 2015
Virological failure in two patients with HIV-1 RNA viral loads >1,000,000 copies/ml initiated on elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarateJessica L Adams, Dana Byrne, Rosalie Pepe, et al.
Journal of the American Chemical Society|March 31, 2005
Hammett analysis of selective thyroid hormone receptor modulators reveals structural and electronic requirements for hormone antagonistsNgoc-Ha Nguyen, James W Apriletti, John D Baxter, et al.
Journal of Medicinal Chemistry|June 27, 2003
Structural determinants of selective thyromimeticsHikari A I Yoshihara, James W Apriletti, John D Baxter, et al.
Biochemistry|June 19, 2008
Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptorM Jeyakumar, Paul Webb, John D Baxter, et al.
Bioorganic & Medicinal Chemistry|December 14, 2001
Synthesis and biological activity of novel thyroid hormone analogues: 5'-aryl substituted GC-1 derivativesGrazia Chiellini, Ngoc Ha Nguyen, James W Apriletti, et al.
Proteins|September 19, 2008
Molecular basis for dimer formation of TRbeta variant D355RNatalia Jouravel, Elena Sablin, Marie Togashi, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 30, 2005
Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand designMarie Togashi, Sabine Borngraeber, Ben Sandler, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 22, 2011
Structural basis of coactivation of liver receptor homolog-1 by β-cateninFumiaki Yumoto, Phuong Nguyen, Elena P Sablin, et al.
Pageof 9

Showing results (11-20 of 81) with videos related to

Sort By:
Pageof 9
Open Forum Infectious Diseases|August 13, 2025
HIV-1 Drug Resistance Trends in the Era of Modern Antiretrovirals: 2018-2024Ron M Kagan, John D Baxter, Taekkyun Kim, et al.
Molecular and Cellular Endocrinology|May 12, 2004
Towards selectively modulating mineralocorticoid receptor function: lessons from other systemsJohn D Baxter, John W Funder, James W Apriletti, et al.
Antiviral Therapy|August 27, 2015
Virological failure in two patients with HIV-1 RNA viral loads >1,000,000 copies/ml initiated on elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarateJessica L Adams, Dana Byrne, Rosalie Pepe, et al.
Journal of the American Chemical Society|March 31, 2005
Hammett analysis of selective thyroid hormone receptor modulators reveals structural and electronic requirements for hormone antagonistsNgoc-Ha Nguyen, James W Apriletti, John D Baxter, et al.
Journal of Medicinal Chemistry|June 27, 2003
Structural determinants of selective thyromimeticsHikari A I Yoshihara, James W Apriletti, John D Baxter, et al.
Biochemistry|June 19, 2008
Quantification of ligand-regulated nuclear receptor corepressor and coactivator binding, key interactions determining ligand potency and efficacy for the thyroid hormone receptorM Jeyakumar, Paul Webb, John D Baxter, et al.
Bioorganic & Medicinal Chemistry|December 14, 2001
Synthesis and biological activity of novel thyroid hormone analogues: 5'-aryl substituted GC-1 derivativesGrazia Chiellini, Ngoc Ha Nguyen, James W Apriletti, et al.
Proteins|September 19, 2008
Molecular basis for dimer formation of TRbeta variant D355RNatalia Jouravel, Elena Sablin, Marie Togashi, et al.
The Journal of Steroid Biochemistry and Molecular Biology|April 30, 2005
Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand designMarie Togashi, Sabine Borngraeber, Ben Sandler, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 22, 2011
Structural basis of coactivation of liver receptor homolog-1 by β-cateninFumiaki Yumoto, Phuong Nguyen, Elena P Sablin, et al.
Pageof 9